Efficacy and safety of warfarin therapy in patients with atrial fibrillation using genotype-guided dosing method
The aim. To evaluate the efficacy and safety of warfarin (WF) therapy in patients with atrial fibrillation (AF) using pharmacogenetic dosing method at an anticoagulant monitoring office according to the results of a one-year prospective follow-up. Materials and methods. The study involved 110 pat...
Main Authors: | M. Yu. Kolesnyk, Ya. M. Mykhailovskyi |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2022-09-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/256945/260193 |
Similar Items
-
The influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation
by: Ya. M. Mykhailovskyi
Published: (2022-06-01) -
The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01) -
Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
by: Jinhua Zhang, et al.
Published: (2020-01-01) -
Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
by: Nita A Limdi, et al.
Published: (2012-10-01) -
Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
by: T. A. Bairova, et al.
Published: (2019-07-01)